Uploaded August 2026 | Updated September 2026, 2 weeks ago

---

Moderna (MRNA) rallied more than 130% in a single day while Merck (MRK) also saw substantial gains on Wednesday when both companies shared that phase 3 trials of a melanoma vaccine showed positive results. Jenny Horne talks the triple-digit rally in Moderna and the excitement the news generates for the healthcare space.

======== Schwab Network ========
Empowering every investor and trader, every market day.

Subscribe to the Market Minute newsletter - schwabnetwork.com/subscribe
Download the iOS app - apps.apple.com/us/app/schwab-network/id1460719185
Download the Amazon Fire Tv App - amazon.com/TD-Ameritrade-Network/dp/B07KRD76C7
Watch on Sling - watch.sling.com/1/asset/191928615bd8d47686f94682aefaa007/watch
Watch on Vizio - vizio.com/en/watchfreeplus-explore
Watch on DistroTV - distro.tv/live/schwab-network
Follow us on X – twitter.com/schwabnetwork
Follow us on Facebook – facebook.com/schwabnetwork
Follow us on LinkedIn - linkedin.com/company/schwab-network

About Schwab Network - schwabnetwork.com/about

#moderna #merck #vaccine #economy #finance #investing #marketnews #stock #stockmarket #trading #live #schwabnetwork #mrna #mrk #cancer #melanoma #drugtrial #treatment #healthcare